Research program

Mapping the hidden networks behind everyday data.

API Automations runs a research program alongside its products. Public, licensed and consented data is normalized into source-attributed, aggregate signals under one governance standard, and every result is published with the method, the data and the disclosures that produced it.

Health & medical data research

A separate track, run to a clinician’s question.

Federal health agencies publish a great deal of data that is rarely analyzed at the moment it would matter: adverse-event reports, device clearances and recalls, registered trials and their results, and the public comments that shape the guidance those agencies issue. This track takes a question a clinician actually has, builds a reproducible, dated extract of the public data that bears on it, and puts the answer where it can change something: a regulatory docket first, then the peer-reviewed literature.

Clinical outputs are led by each project’s clinical lead; data outputs by API Automations. Code, data and disclosures are published alongside every result.

Explore the health track →
Open public comment
Nov 24 2026
Deadline for comment on FDA’s draft guidance for robotically assisted surgical devices, docket FDA-2026-N-9505. Our clinician-data comment and study are in progress.
FDA docketPre-registeredPublic federal data

Robotic surgical devices project

Photo by Adrien on Unsplash

Core research domains

Four lenses on digital data.

Every project on this page sits in one of four domains. The domain fixes the question; the pipeline and the gates further down fix how it is answered.

01

Connected Device & Platform Telemetry

How consumer devices, CTV platforms and advertising SDKs transmit data across networks. Telemetry mapping identifies opaque behaviors and supports privacy-centric design standards.

02

Public Data Infrastructure & API Governance

The transparency and accessibility of institutional APIs (civic, governmental and regulatory datasets), studied to inform equitable, accountable data governance. Active projects: PEPI Index, Estate Index, Cannabis Research Index & Civic Forecast.

03

Health & Medical Data Research

A separate track: reproducible analyses of public federal health data, from adverse-event surveillance to regulatory dockets. Clinical outputs are led by clinicians and data outputs by API Automations, published with the code, the data and the disclosures.

Read about the track
04

Privacy Literacy & Public Awareness

Technical findings turned into public education through Data Privacy Today, including the “What You Need to Know in 90 Seconds” series.

Research outputs

Live indexes, a research model, and the papers.

Each output comes from the same pipeline. The indexes are computed from public filings and official statistics, the model answers against sourced records, and the papers are the analyses that went to a docket or a journal. Every output links to its live site; a gated one opens on its own sign-in and says so on the card.

In-house figures

What the indexes and the registers hold, as of their last snapshot.

Every number here names where it comes from. The Cannabis Research Index figures are copied, with their date, from the index’s own source register; the health figures are computed at build time from the dated registers the project keeps, so a chart cannot drift from its file.

Cannabis Research Index
38
Source families registered, 5 with observations today
Cannabis Research Index
9
Jurisdictions, domestic and international
Cannabis Research Index
202
Series definitions
Cannabis Research Index
1,162
Observations held, 1,048 of them numeric
Cannabis Research Index
2014
Longest series runs back to
PEPI Index
15+
Public sources ingested
Health research
21
Registered trials in the RASD register, snapshot 2026-09-29
Health research
9
Verified references in the literature register, 2026-09-29
  • Cannabis Research Index: Cannabis Research Index source register, canri.apiautomations.com/coverage, as of 2026-09-09
  • PEPI Index: Source count as stated in the PEPI product description
Registered trials by phaseTrials in the RASD project's ClinicalTrials.gov register, counted by their registered phase.
Not applicable: 10Not applicable10Phase 4: 8Phase 48Phase 3: 1Phase 31Phase 1: 1Phase 11Not stated: 1Not stated1
View as a table
CategoryCount
Not applicable10
Phase 48
Phase 31
Phase 11
Not stated1

ClinicalTrials.gov registry snapshot · snapshot 2026-09-29

Literature register by publication yearPeer-reviewed references the project has verified, by year of publication.
2014: 1201412016: 1201612017: 1201712019: 1201912021: 1202112022: 1202212025: 1202512026: 220262
View as a table
CategoryCount
20141
20161
20171
20191
20211
20221
20251
20262

Project literature register, verified · snapshot 2026-09-29

Cannabis Research Index register by jurisdictionSource families the index has registered, by the jurisdiction or body that publishes them.
United States: 21United States21Canada: 8Canada8International bodies: 2International bodies2Research registries: 2Research registries2Uruguay: 1Uruguay1Germany: 1Germany1Portugal: 1Portugal1Switzerland: 1Switzerland1Australia: 1Australia1
View as a table
CategoryCount
United States21
Canada8
International bodies2
Research registries2
Uruguay1
Germany1
Portugal1
Switzerland1
Australia1

Cannabis Research Index source register · snapshot 2026-09-09

How to read it

Registration is not collection. Every family here has been assessed and admitted to the register, and 5 of them supply observations today, the largest being Canada’s national statistics agency. The rest are listed so the gaps are visible rather than implied.

The register is the index’s own, published on its coverage page. Values, period-level history and series definitions are licensed rather than published, so none of them appear here.

Figures for the access-controlled products are not shown here. They are reported to licensed users under the terms of their agreement rather than published to the open web.

Photo by Steve A Johnson on Unsplash

How the research is run

One method, stated in full.

Governance is a claim about how something is run, so here is the run: the pipeline every source moves through, the boundaries on what a supplier’s data can become, the commitments made to every provider, and the gates a manuscript passes before it leaves. Open each for the detail.

The governed pipelineSix stages, in order. No stage re-exposes source records, which is what makes a derived index publishable where the records behind it are not.
01

Acquisition

Authorized API access or licensed feeds, with caching, retries, and rate-limit compliance, and only ever through a provider's sanctioned method and credentials.

02

Normalization

Mapped into internal schemas with source provenance preserved as a first-class field rather than reconstructed later from memory.

03

Alignment

Joined to the stable geographic and entity identifiers each source supports, so records aggregate without record-level exposure.

04

Derivation

Aggregates, deltas, rates, per-capita values, severity bands, and topic tags. Transformative indicators, not the source records.

05

Delivery

Indices, cards, and curated delivery to licensed destinations, with source attribution carried onto every surface it lands on.

06

Measurement

Aggregate usage only: counts, rates, cohorts, and geography or topic buckets. No user-level export; partner reporting is aggregate-only.

Where the line sitsWhat the program is not, stated plainly, because it bounds how any supplier's data can be used here, and a boundary a partner cannot check is not a boundary.
01

Not a news publisher

We do not republish source content as journalism, and we do not hold ourselves out as a newsroom.

02

Not an unlicensed channel

We operate a licensed marketplace, so data does move through us. What never moves is a record outside the terms it was licensed under, or to a recipient its consent does not cover.

03

Not a substitute dataset

We do not reconstruct a provider's dataset, offer a queryable record store, or build a competitor to their product.

04

Not an ad-tech tracking product

No cross-app tracking underwrites anything we build. Consent travels with the record, and enforcement happens inline.

Licensing-safe commitmentsThe same undertaking for every data partner, regardless of who the provider is or what the source costs.
We will
  • Confirm the applicable license class before any public use.
  • Access data only through a provider's authorized method and credentials.
  • Publish only transformed, aggregated outputs that cannot reconstruct the source records.
  • Attribute the provider prominently, with access date, filters used, and transformations applied.
  • Keep each source as one input within a broader, nonpartisan framework.
  • Respond promptly to corrections, takedown, or access-revocation requests.
We will not
  • Scrape, mirror, or use unauthorized access paths.
  • Redistribute raw records, expose a queryable record store, or offer export.
  • Strip, hide, or genericize attribution.
  • Build a substitute for, or a competitor to, a provider's own product.
  • Use a source to train or improve automated systems outside its license scope.
  • Contest good-faith provider enforcement of its terms.

The full sourcing and attribution practice is set out in Open APIs & Public Data.

Publishing gatesFive gates a manuscript passes before it leaves, each answered in writing. There are no partial sign-offs.
01

Provenance

Every input is named and classified. A restricted input stops the paper.

02

Venue

A source, a journal, and an index are three different things, and only one of them accepts a manuscript.

03

Ethics

We hold no review board of our own, so a determination is obtained from one qualified to make it, never assumed.

04

Licensing

Cleared per source, including the separate act of publishing a figure derived from it.

05

Disclosure

The commercial structure behind the work, and any industry payments to the authors, are both declared.

The cleanest route through the ethics gate is an academic collaborator whose institution acts as review board of record. That is a real dependency rather than a courtesy, and we would rather say so. Partners get a documented method, a governed pipeline, and a corpus that is already computed, not a data dump to clean.

Research methodology

Rigor, reproducibility, ethical integrity.

Empirical analysis combined with system-level inspection. Every experiment runs in a controlled, consented data environment and is documented for peer review and open publication.

Network & Telemetry AnalysisAPI Behavior MappingPolicy & Disclosure VerificationCross-Device Comparative Testing
Our vision
Transparency
Bringing clarity and accountability to the systems that shape everyday digital life.
ConsentDisclosureReform

Collaborate with us.

We work with institutes, clinicians, journalists, and industry partners advancing data ethics, privacy innovation, and API standardization.